KabaFusion, a Cerritos, Calif.-based provider of specialty acute and chronic home infusion therapies, acquired the home infusion assets of Lincare, a subsidiary of Linde plc.
The amount of the deal was not disclosed.
The addition of Lincare’s infusion operations expands KabaFusion’s footprint to 28 home infusion specialty pharmacies, adding key strategic markets in Alabama, Arkansas, Florida, Indiana, Kentucky, Michigan, New Jersey, New York, North Carolina, Virginia and Wyoming. Together with KabaFusion’s existing pharmacies in California, Florida, Illinois, Massachusetts, New Jersey, Pennsylvania and Texas, the company is licensed to serve patients in 44 states with a comprehensive offering of acute, chronic and enteral therapies.
Founded by Dr. Sohail Masood, Pharm D., in 2010, Chief Executive Officer, KabaFusion has been a pioneering leader in patient-focused home infusion services with deep clinical expertise in intravenous immunoglobulin (IVIG) therapies. KabaFusion’s clinician-led management team will continue to lead the combined company in working with patients, healthcare providers, hospitals and payors across the United States to deliver the highest quality home infusion services with unmatched clinical excellence. Terms of the transaction were not disclosed.
The transaction marks KabaFusion’s first acquisition since partnering with Pritzker Private Capital in January 2019.
FinSMEs
06/03/2020